Cite

    Moneeb Nasir et al.. “Impact of rituximab regime on time to relapse in aquaporin-4 antibody positive neuromyelitis spectrum disorder.” Journal of neurology, neurosurgery and psychiatry, vol. 93, no. 9, 2022, pp. e2–. http://access.bl.uk/ark:/81055/vdc_100161680582.0x00004e